Compare AQMS & BNGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | AQMS | BNGO |
|---|---|---|
| Founded | 2014 | 2003 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Biotechnology: Laboratory Analytical Instruments |
| Sector | Industrials | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 12.8M | 12.5M |
| IPO Year | 2015 | 2018 |
| Metric | AQMS | BNGO |
|---|---|---|
| Price | $4.03 | $1.23 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | ★ $12.00 | $7.00 |
| AVG Volume (30 Days) | 32.6K | ★ 281.9K |
| Earning Date | 05-07-2026 | 05-13-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 94.50 |
| EPS | N/A | ★ N/A |
| Revenue | $2,100,000.00 | ★ $12,000,735.00 |
| Revenue This Year | N/A | $16.19 |
| Revenue Next Year | $600.00 | $33.34 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ 26.26 |
| 52 Week Low | $0.34 | $1.06 |
| 52 Week High | $39.37 | $5.50 |
| Indicator | AQMS | BNGO |
|---|---|---|
| Relative Strength Index (RSI) | 46.13 | 55.10 |
| Support Level | $4.01 | $1.08 |
| Resistance Level | $4.47 | $1.64 |
| Average True Range (ATR) | 0.29 | 0.05 |
| MACD | 0.04 | 0.01 |
| Stochastic Oscillator | 56.52 | 96.43 |
Aqua Metals Inc is engaged in the business of recycling Lead through a novel, proprietary and patent-pending process that it developed and named AquaRefining. The company's breakthrough, AquaRefining, delivers a product, at a higher yield, eliminates toxic waste, reduces permitting, and is less expensive to build than smelting. AquaRefining process will provide for the recycling of Lead acid batteries and the production of a pure grade Lead with a significantly lower cost of production, and with fewer environmental and regulatory issues, than conventional methods of Lead production.
Bionano Genomics Inc is a life sciences instrumentation company in the genome analysis space. It is engaged in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline the study of changes in chromosomes. Geographically, it operates in the Americas, EMEA, and Asia Pacific, of which the EMEA region generates the majority of its revenue. It generates product revenue from sales of its OGM and Ionic Purification systems and consumables, which include its instruments and their VIA software.